Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin
Year: 2020
Type: article
Study design: Observational Study
Authors: Talha Badar, Aniko Szabo, Martha Wadleigh, Michaela Liedtke, Shukaib Arslan, Caitlin Siebenaller, Ibrahim Aldoss, Elizabeth Schultz, Mehrdad Hefazi, Mark R. Litzow, Eric Kuo, Amy Wang, Emily Curran, Rory M. Shallis, Nikolai Podoltsev, Suresh Balasubramanian, Jay Yang, Ryan Mattison, Madelyn Burkart, Shira Dinner, Anjali Advani, Ehab Atallah
Institutions: Medical College of Wisconsin, Dana-Farber Cancer Institute, Stanford Medicine, Stanford University, City Of Hope National Medical Center, City of Hope, Cleveland Clinic, Mayo Clinic, University of Chicago, Yale University, The Barbara Ann Karmanos Cancer Institute, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: GlycoMimetics, Boehringer Ingelheim, Amgen, Pfizer, Novartis, Celgene, AbbVie, Jazz Pharmaceuticals, Astex Pharmaceuticals, LAM Therapeutics, Sunesis, Arog Pharmaceuticals, CTI Biopharma, MacroGenics, Daiichi-Sankyo, Astellas Pharma, Genentech, Astellas Pharma Global Development, Daiichi Sankyo Europe
OpenAlex ID: W3012219229